Viral Hemorrhagic Fevers
Philip W. Smith, MD
http://webmedia.unmc.edu
Filoviruses
http://www.unco.edu
HIV-1 and Ebola virus
Juan Martin-Serrano, Trinity Zang & Paul D. Bieniasz
http://www.csus.edu
Ebola Virus Outbreak
Erin Goode
http://facstaff.bloomu.edu
Concerns that Ebola may be transmitted through air
Gil Rivera
http://alpha.lasalle.edu/
Viral Hemorrhagic Fevers - Filoviridae
http://www.uky.edu
Ebola
Karan Chopra, Mohan Bolisetty
http://www.rci.rutgers.edu
Scientific Name: Ebola Virus
http://www.pleasval.k12.ia.us/highschool
Ebola - The Deadly African Virus
Claudia Hacker
http://www2.yk.psu.edu
Ebola Virus - Hemorrhagic Fever
http://homepage.smc.edu
Viral Hemorrhagic Fever
http://www.cfsph.iastate.edu
Ebola Hemorrhagic Fever
Anderson Coates, Michael Mastropole
http://courses.bio.unc.edu
Hemorrhagic Fevers
http://www.columbia.edu Marburg.ppt
Case Study- Ebola Virus
Shahrzad Morim, Monica Delgado, Janine Gilkes
http://instructional1.calstatela.edu/
Latest 200 Published articles on Ebola Virus
1. Health ministers in west Africa hold crisis talks on Ebola virus
Gulland, Anne
BMJ-BRITISH MEDICAL JOURNAL Volume: 349 Pages: G4478-G4478 Published: JUL 7 2014
2. Outbreak of ebola virus disease in Guinea: where ecology meets economy.
Bausch, Daniel G; Schwarz, Lara
PLoS neglected tropical diseases Volume: 8 Issue: 7 Pages: e3056 Published: 2014-Jul
3. Digital Sensing and Sizing of Vesicular Stomatitis Virus Pseudotypes in Complex Media: A Model for Ebola and Marburg Detection
Daaboul, George G.; Lopez, Carlos A.; Chinnala, Jyothsna; et al.
ACS NANO Volume: 8 Issue: 6 Pages: 6047-6055 Published: JUN 2014
4. Une premiere epidemie de fievre a virus Ebola en Afrique del'Ouest.
[A first outbreak of Ebola virus in West Africa].
Reynard, Olivier; Volchkov, Viktor; Peyrefitte, Christophe
Medecine sciences : M/S Volume: 30 Issue: 6-7 Pages: 671-3 Published: 2014 Jun-Jul (Epub 2014 Jul 11)
5. High-throughput, luciferase-based reverse genetics systems for identifying inhibitors of Marburg and Ebola viruses
Uebelhoer, Luke S.; Albarino, Cesar G.; McMullan, Laura K.; et al.
ANTIVIRAL RESEARCH Volume: 106 Pages: 86-94 Published: JUN 2014
6. Characterization of host immune responses in Ebola virus infections
Wong, Gary; Kobinger, Gary P.; Qiu, Xiangguo
EXPERT REVIEW OF CLINICAL IMMUNOLOGY Volume: 10 Issue: 6 Pages: 781-790 Published: JUN 2014
7. Evolutionary history of Ebola virus
Li, Y. H.; Chen, S. P.
EPIDEMIOLOGY AND INFECTION Volume: 142 Issue: 6 Pages: 1138-1145 Published: JUN 2014
8. Compositions and methods for inhibiting expression of a gene from the Ebola virus
Patent Number: US 08735369
Patent Assignee: Alnylam Pharmaceuticals Inc; The United States of America as represented by the Secretary of the Army
Inventor(s): Bavari, Sina; Warfield, Kelly Lyn; Tan, Pamela; et al.
Official Gazette of the United States Patent and Trademark Office Patents Published: MAY 27 2014
9. Outbreak news. Ebola virus disease, West Africa.
[Anonymous]
Releve epidemiologique hebdomadaire / Section d'hygiene du Secretariat de la Societe des Nations = Weekly epidemiological record / Health Section of the Secretariat of the League of Nations Volume: 89 Issue: 20 Pages: 205-6 Published: 2014-May-16
10. Compositions and methods for silencing Ebola virus gene expression
Patent Number: US 08716464
Inventor(s): Geisbert, Thomas W.; Lee, Amy C. H.; Robbins, Marjorie; et al.
Official Gazette of the United States Patent and Trademark Office Patents Published: MAY 6 2014
11. Vigilances autour du virus Ebola.
[In Process Citation].
Warnet, Sylvie
Revue de l'infirmiere Volume: 201 Pages: 10 Published: 2014-May
12. Ebola virus disease in western Africa
[Anonymous]
BULLETIN OF THE WORLD HEALTH ORGANIZATION Volume: 92 Issue: 5 Pages: 313-313 Published: MAY 2014
13. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model
Oestereich, Lisa; Luedtke, Anja; Wurr, Stephanie; et al.
ANTIVIRAL RESEARCH Volume: 105 Pages: 17-21 Published: MAY 2014
14. Ebola virus in West Africa.
Du Toit, Andrea
Nature reviews. Microbiology Volume: 12 Issue: 5 Pages: 312 Published: 2014-Apr-16
15. Pourquoi le virus Ebola (qui sevit aujourd'hui en Guinee) ne nous effraie-t-il pas?
[Why does the Ebola virus (which is prevalent in Guinea today) not scare us?].
Nau, Jean-Yves
Revue medicale suisse Volume: 10 Issue: 425 Pages: 834-5 Published: 2014-Apr-9
16. Ebola virus vaccines: an overview of current approaches
Marzi, Andrea; Feldmann, Heinz
EXPERT REVIEW OF VACCINES Volume: 13 Issue: 4 Pages: 521-531 Published: APR 2014
17. Post-exposure efficacy of Oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model
Smither, Sophie J.; Eastaugh, Lin S.; Steward, Jackie A.; et al.
ANTIVIRAL RESEARCH Volume: 104 Pages: 153-155 Published: APR 2014
18. Identification of a Broad-Spectrum Antiviral Small Molecule against Severe Acute Respiratory Syndrome Coronavirus and Ebola, Hendra, and Nipah Viruses by Using a Novel High-Throughput Screening Assay
Elshabrawy, Hatem A.; Fan, Jilao; Haddad, Christine S.; et al.
JOURNAL OF VIROLOGY Volume: 88 Issue: 8 Pages: 4353-4365 Published: APR 2014
19. Vaccination with recombinant adenoviruses expressing Ebola virus glycoprotein elicits protection in the interferon alpha/beta receptor knock-out mouse
O'Brien, Lyn M.; Stokes, Margaret G.; Lonsdale, Stephen G.; et al.
VIROLOGY Volume: 452 Pages: 324-333 Published: MAR 2014
20. Toll-Like Receptor Agonist Augments Virus-Like Particle-Mediated Protection from Ebola Virus with Transient Immune Activation
Martins, Karen A. O.; Steffens, Jesse T.; van Tongeren, Sean A.; et al.
PLOS ONE Volume: 9 Issue: 2 Article Number: e89735 Published: FEB 24 2014
21. Clinical Documentation and Data Transfer from Ebola and Marburg Virus Disease Wards in Outbreak Settings: Health Care Workers' Experiences and Preferences
Buehler, Silja; Roddy, Paul; Nolte, Ellen; et al.
VIRUSES-BASEL Volume: 6 Issue: 2 Pages: 927-937 Published: FEB 2014
22. Could the Ebola virus matrix protein VP40 be a drug target?
Stahelin, Robert V.
EXPERT OPINION ON THERAPEUTIC TARGETS Volume: 18 Issue: 2 Pages: 115-120 Published: FEB 2014
23. Ebola Virus-Like Particles Stimulate Type I Interferons and Proinflammatory Cytokine Expression Through the Toll-Like Receptor and Interferon Signaling Pathways
Ayithan, Natarajan; Bradfute, Steven B.; Anthony, Scott M.; et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH Volume: 34 Issue: 2 Pages: 79-89 Published: FEB 1 2014
24. The Ebola Virus Matrix Protein Bends Biological Membranes
Soni, Smita P.; Stahelin, Robert V.
Conference: 58th Annual Meeting of the Biophysical-Society Location: San Francisco, CA Date: FEB 15-19, 2014
Sponsor(s): Biophys Soc
BIOPHYSICAL JOURNAL Volume: 106 Issue: 2 Supplement: 1 Pages: 513A-513A Published: JAN 28 2014
25. Structural Rearrangement of the Ebola Virus VP40 Protein Begets Multiple Functions in the Virus Life Cycle
Saphire, Erica Ollmann; Bornholdt, Zachary A.; Abelson, Dafna M.; et al.
Conference: 58th Annual Meeting of the Biophysical-Society Location: San Francisco, CA Date: FEB 15-19, 2014
Sponsor(s): Biophys Soc
BIOPHYSICAL JOURNAL Volume: 106 Issue: 2 Supplement: 1 Pages: 637A-637A Published: JAN 28 2014
26. Cell-Cell Fusion Mediated by the Fusion Protein of Ebola Virus
Markosyan, Ruben M.; Liu, Shan Lu; Cohen, Fredric S.
Conference: 58th Annual Meeting of the Biophysical-Society Location: San Francisco, CA Date: FEB 15-19, 2014
Sponsor(s): Biophys Soc
BIOPHYSICAL JOURNAL Volume: 106 Issue: 2 Supplement: 1 Pages: 707A-707A Published: JAN 28 2014
27. Health ministers in west Africa hold crisis talks on Ebola virus.
Gulland, Anne
BMJ (Clinical research ed.) Volume: 348 Pages: g4478 Published: 2014 Jul 07
28. Ebola virus disease, West Africa.
Group Author(s): World Health Organization
Weekly Epidemiological Record Volume: 89 Issue: 20 Pages: 205-206 Published: 2014
29. Use of 2,3-dihydroquinazolin-4(1H)-one derivatives for treating infection by (such as filovirus (Ebola virus), adenoviruses, arenavirus or influenza A virus) entering cell by endocytosis
Patent Number: EP2722047-A1; WO2014060588-A1
Patent Assignee: COMMISSARIAT ENERGIE ATOMIQUE; UNIV TEXAS MEDICAL BRANCH
Inventor(s): GILLET D; BARBIER J; DAVEY R; et al.
30. Identification of continuous human B-cell epitopes in the VP35, VP40, nucleoprotein and glycoprotein of Ebola virus.
Becquart, Pierre; Mahlakoiv, Tanel; Nkoghe, Dieudonne; et al.
PloS one Volume: 9 Issue: 6 Pages: e96360 Published: 2014
31. Comprehensive Functional Analysis of N-Linked Glycans on Ebola Virus GP1
Lennemann, Nicholas J.; Rhein, Bethany A.; Ndungo, Esther; et al.
MBIO Volume: 5 Issue: 1 Article Number: e00862-13 Published: JAN-FEB 2014
32. Retinazone inhibits certain blood-borne human viruses including Ebola virus Zaire.
Kesel, Andreas J; Huang, Zhuhui; Murray, Michael G; et al.
Antiviral chemistry & chemotherapy Volume: 23 Issue: 5 Pages: 197-215 Published: 2014 Apr 11
33. Treating a subject infected with or at risk of infection with Ebola, and inhibiting replication of Ebola virus involves use of new and known 2,3-dihydro-1H-cyclopenta(b)quinoline compounds
Patent Number: WO2014028051-A1
Patent Assignee: UNIV HOWARD; NEKHAI S
Inventor(s): NEKHAI S.
34. Emerging Targets and Novel Approaches to Ebola Virus Prophylaxis and Treatment
Choi, Jin Huk; Croyle, Maria A.
BIODRUGS Volume: 27 Issue: 6 Pages: 565-583 Published: DEC 2013
35. The Cytoprotective Enzyme Heme Oxygenase-1 Suppresses Ebola Virus Replication
Hill-Batorski, Lindsay; Halfmann, Peter; Neumann, Gabriele; et al.
JOURNAL OF VIROLOGY Volume: 87 Issue: 24 Pages: 13795-13802 Published: DEC 2013
36. Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb
Qiu, Xiangguo; Audet, Jonathan; Wong, Gary; et al.
SCIENTIFIC REPORTS Volume: 3 Article Number: 3365 Published: NOV 28 2013
37. Development of RNA Aptamers Targeting Ebola Virus VP35
Binning, Jennifer M.; Wang, Tianjiao; Luthra, Priya; et al.
BIOCHEMISTRY Volume: 52 Issue: 47 Pages: 8406-8419 Published: NOV 26 2013
38. Recombinant lentogenic Newcastle disease virus expressing Ebola virus GP infects cells independently of exogenous trypsin and uses macropinocytosis as the major pathway for cell entry
Wen, Zhiyuan; Zhao, Bolin; Song, Kun; et al.
VIROLOGY JOURNAL Volume: 10 Article Number: 331 Published: NOV 9 2013
39. The Lack of Maturation of Ebola Virus-Infected Dendritic Cells Results from the Cooperative Effect of at Least Two Viral Domains vol(87, pg 7471, 2013)
Lubaki, Ndongala M.; Ilinykh, Philipp; Pietzsch, Colette; et al.
JOURNAL OF VIROLOGY Volume: 87 Issue: 22 Pages: 12506-12506 Published: NOV 2013
40. C-peptide inhibitors of Ebola virus glycoprotein-mediated cell entry: Effects of conjugation to cholesterol and side chain-side chain crosslinking
Higgins, Chelsea D.; Koellhoffer, Jayne F.; Chandran, Kartik; et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS Volume: 23 Issue: 19 Pages: 5356-5360 Published: OCT 1 2013
41. Ebola Virus RNA Editing Depends on the Primary Editing Site Sequence and an Upstream Secondary Structure
Mehedi, Masfique; Hoenen, Thomas; Robertson, Shelly; et al.
PLOS PATHOGENS Volume: 9 Issue: 10 Article Number: e1003677 Published: OCT 2013
42. Animal models for Ebola and Marburg virus infections
Nakayama, Eri; Saijo, Masayuki
FRONTIERS IN MICROBIOLOGY Volume: 4 Article Number: 267 Published: SEP 5 2013
43. A novel Ebola virus expressing luciferase allows for rapid and quantitative testing of antivirals
Hoenen, Thomas; Groseth, Allison; Callison, Julie; et al.
ANTIVIRAL RESEARCH Volume: 99 Issue: 3 Pages: 207-213 Published: SEP 2013
44. Mapping of conserved and species-specific antibody epitopes on the Ebola virus nucleoprotein
Changula, Katendi; Yoshida, Reiko; Noyori, Osamu; et al.
VIRUS RESEARCH Volume: 176 Issue: 1-2 Pages: 83-90 Published: SEP 2013
45. Ebola virus weak point identified by researchers
Wilson, Hannah
FUTURE VIROLOGY Volume: 8 Issue: 9 Pages: 838-839 Published: SEP 2013
46. Differences in cytokine responses during infection with high and low pathogenic Ebola viruses
Olejnik, Judith; Marzi, Andrea; Feldmann, Heinz; et al.
Conference: Annual Joint Conference of the International-Cytokine-Society and the International-Society-for-Interferon-and-Cytokine-Research Location: San Francisco, CA Date: SEP 29-OCT 03, 2013
Sponsor(s): Int Cytokine Soc; Int Soc Interferon & Cytokine Res
CYTOKINE Volume: 63 Issue: 3 Special Issue: SI Pages: 287-288 Published: SEP 2013
47. Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail.
Pettitt, James; Zeitlin, Larry; Kim, Do H; et al.
Science translational medicine Volume: 5 Issue: 199 Pages: 199ra113 Published: 2013-Aug-21
48. Therapeutic Intervention of Ebola Virus Infection in Rhesus Macaques with the MB-003 Monoclonal Antibody Cocktail
Pettitt, James; Zeitlin, Larry; Kim, Do H.; et al.
SCIENCE TRANSLATIONAL MEDICINE Volume: 5 Issue: 199 Published: AUG 21 2013
49. Therapeutic Intervention of Ebola Virus Infection in Rhesus Macaques with the MB-003 Monoclonal Antibody Cocktail
[Anonymous]
SCIENCE TRANSLATIONAL MEDICINE Volume: 5 Issue: 199 Article Number: 199ra113 Published: AUG 21 2013
50. Monoclonal antibodies for Ebola and Marburg viruses
Patent Number: US 08513391
Inventor(s): Jones, Steven; Qiu, Xiangguo; Feldmann, Heinz; et al.
Official Gazette of the United States Patent and Trademark Office Patents Published: AUG 20 2013
51. Structural Rearrangement of Ebola Virus VP40 Begets Multiple Functions in the Virus Life Cycle
Bornholdt, Zachary A.; Noda, Takeshi; Abelson, Dafna M.; et al.
CELL Volume: 154 Issue: 4 Pages: 763-774 Published: AUG 15 2013
52. DNA Topoisomerase 1 Facilitates the Transcription and Replication of the Ebola Virus Genome
Takahashi, Kei; Halfmann, Peter; Oyama, Masaaki; et al.
JOURNAL OF VIROLOGY Volume: 87 Issue: 16 Pages: 8862-8869 Published: AUG 2013
53. Persistent Immune Responses after Ebola Virus Infection
Sobarzo, Ariel; Ochayon, David E.; Lutwama, Julius J.; et al.
NEW ENGLAND JOURNAL OF MEDICINE Volume: 369 Issue: 5 Pages: 492-493 Published: AUG 1 2013
54. Mutual Antagonism between the Ebola Virus VP35 Protein and the RIG-I Activator PACT Determines Infection Outcome
Luthra, Priya; Ramanan, Parameshwaran; Mire, Chad E.; et al.
CELL HOST & MICROBE Volume: 14 Issue: 1 Pages: 74-84 Published: JUL 17 2013
55. The L-VP35 and L-L interaction domains reside in the amino terminus of the Ebola virus L protein and are potential targets for antivirals
Trunschke, Martina; Conrad, Dominik; Enterlein, Sven; et al.
VIROLOGY Volume: 441 Issue: 2 Pages: 135-145 Published: JUL 5 2013
56. The Lack of Maturation of Ebola Virus-Infected Dendritic Cells Results from the Cooperative Effect of at Least Two Viral Domains
Lubaki, Ndongala M.; Ilinykh, Philipp; Pietzsch, Colette; et al.
JOURNAL OF VIROLOGY Volume: 87 Issue: 13 Pages: 7471-7485 Published: JUL 2013
57. Monoclonal Antibodies Combined with Adenovirus-Vectored Interferon Significantly Extend the Treatment Window in Ebola Virus-Infected Guinea Pigs
Qiu, Xiangguo; Wong, Gary; Fernando, Lisa; et al.
JOURNAL OF VIROLOGY Volume: 87 Issue: 13 Pages: 7754-7757 Published: JUL 2013
58. Host IQGAP1 and Ebola Virus VP40 Interactions Facilitate Virus-Like Particle Egress
Lu, Jianhong; Qu, Yonggang; Liu, Yuliang; et al.
JOURNAL OF VIROLOGY Volume: 87 Issue: 13 Pages: 7777-7780 Published: JUL 2013
59. Mechanisms of immunosuppression in viral infections: From retroviruses to Ebola and influenza viruses
Kiselev, O.
Conference: 38th Congress of the Federation-of-European-Biochemical-Societies (FEBS) Location: Saint Petersburg, RUSSIA Date: JUL 06-11, 2013
Sponsor(s): Federat European Biochemical Soc
FEBS JOURNAL Volume: 280 Special Issue: SI Supplement: 1 Pages: 353-353 Published: JUL 2013
60. Induction of neutralizing antibody in mice by plasmid DNA encoding envelope glycoprotein of Ebola virus
He Li-fang; Wu Wen-jun; Wang Li-li; et al.
Chinese Journal of Biologicals Volume: 26 Issue: 6 Pages: 866-868 Published: JUN 20 2013
61. FDA-Approved Selective Estrogen Receptor Modulators Inhibit Ebola Virus Infection
Johansen, Lisa M.; Brannan, Jennifer M.; Delos, Sue E.; et al.
SCIENCE TRANSLATIONAL MEDICINE Volume: 5 Issue: 190 Article Number: 190ra79 Published: JUN 19 2013
62. Ebola virus VP35 induces high-level production of recombinant TPL-2-ABIN-2 NF-kappa B1 p105 complex in co-transfected HEK-293 cells
Gantke, Thorsten; Boussouf, Sabrina; Janzen, Julia; et al.
BIOCHEMICAL JOURNAL Volume: 452 Pages: 359-365 Part: 2 Published: JUN 1 2013
63. The Ebola Virus Matrix Protein Deeply Penetrates the Plasma Membrane: An Important Step in Viral Egress
Soni, Smita P.; Adu-Gyamfi, Emmanuel; Yong, Sylvia S.; et al.
BIOPHYSICAL JOURNAL Volume: 104 Issue: 9 Pages: 1940-1949 Published: MAY 7 2013
64. A novel mechanism of immune evasion mediated by Ebola virus soluble glycoprotein
Basler, Christopher F.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY Volume: 11 Issue: 5 Pages: 475-478 Published: MAY 2013
65. Ebola Virus Does Not Block Apoptotic Signaling Pathways
Olejnik, Judith; Alonso, Jesus; Schmidt, Kristina M.; et al.
JOURNAL OF VIROLOGY Volume: 87 Issue: 10 Pages: 5384-5396 Published: MAY 2013
66. Antibody Quality and Protection from Lethal Ebola Virus Challenge in Nonhuman Primates Immunized with Rabies Virus Based Bivalent Vaccine
Blaney, Joseph E.; Marzi, Andrea; Willet, Mallory; et al.
PLOS PATHOGENS Volume: 9 Issue: 5 Article Number: e1003389 Published: MAY 2013
67. Phosphorylation of Ebola Virus VP30 Influences the Composition of the Viral Nucleocapsid Complex IMPACT ON VIRAL TRANSCRIPTION AND REPLICATION
Biedenkopf, Nadine; Hartlieb, Bettina; Hoenen, Thomas; et al.
JOURNAL OF BIOLOGICAL CHEMISTRY Volume: 288 Issue: 16 Pages: 11165-11174 Published: APR 19 2013
68. Control of fusion activities of HIV GP41 and Ebola virus fusion domains by membrane lipids
Gregory, Sonia M.; Lai, Alex L.; Yang, Sung-Tae; et al.
Conference: 245th National Meeting of the American-Chemical-Society (ACS) Location: New Orleans, LA Date: APR 07-11, 2013
Sponsor(s): Amer Chem Soc
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY Volume: 245 Meeting Abstract: 241-COLL Published: APR 7 2013
69. Lectin-Dependent Enhancement of Ebola Virus Infection via Soluble and Transmembrane C-type Lectin Receptors
Brudner, Matthew; Karpel, Marshall; Lear, Calli; et al.
PLOS ONE Volume: 8 Issue: 4 Article Number: e60838 Published: APR 2 2013
70. Lipid binding properties of Ebola virus matrix protein VP40
Yong, Sylvia; Scott, Jordan L.; Stahelin, Robert V.
Conference: Joint Annual Meeting of the ASPET/BPS at Experimental Biology (EB) Location: Boston, MA Date: APR 20-24, 2013
Sponsor(s): ASPET; British Pharmacol Soc (BPS)
FASEB JOURNAL Volume: 27 Meeting Abstract: 1021.9 Published: APR 2013
71. Airway Delivery of an Adenovirus-Based Ebola Virus Vaccine Bypasses Existing Immunity to Homologous Adenovirus in Nonhuman Primates
Richardson, Jason S.; Pillet, Stephane; Bello, Alexander J.; et al.
JOURNAL OF VIROLOGY Volume: 87 Issue: 7 Pages: 3668-3677 Published: APR 2013
72. Ebola Virus Exploits a Monocyte Differentiation Program To Promote Its Entry
Martinez, Osvaldo; Johnson, Joshua C.; Honko, Anna; et al.
JOURNAL OF VIROLOGY Volume: 87 Issue: 7 Pages: 3801-3814 Published: APR 2013
73. Expression of Concern: Serological Evidence of Ebola Virus Infection in Indonesian Orangutans
[Anonymous]
PLOS ONE Volume: 8 Issue: 3 Article Number: e60289 Published: MAR 20 2013
74. A Mutation in the Ebola Virus Envelope Glycoprotein Restricts Viral Entry in a Host Species- and Cell-Type-Specific Manner
Martinez, Osvaldo; Ndungo, Esther; Tantral, Lee; et al.
JOURNAL OF VIROLOGY Volume: 87 Issue: 6 Pages: 3324-3334 Published: MAR 2013
75. [Research progress on ebola virus glycoprotein].
Ding, Guo-Yong; Wang, Zhi-Yu; Gao, Lu; et al.
Bing du xue bao = Chinese journal of virology / [bian ji, Bing du xue bao bian ji wei yuan hui] Volume: 29 Issue: 2 Pages: 233-7 Published: 2013-Mar
76. The Ebola Virus Matrix Protein Penetrates into the Plasma Membrane A KEY STEP IN VIRAL PROTEIN 40 (VP40) OLIGOMERIZATION AND VIRAL EGRESS
Adu-Gyamfi, Emmanuel; Soni, Smita P.; Xue, Yi; et al.
JOURNAL OF BIOLOGICAL CHEMISTRY Volume: 288 Issue: 8 Pages: 5779-5789 Published: FEB 22 2013
77. Multiple Cationic Amphiphiles Induce a Niemann-Pick C Phenotype and Inhibit Ebola Virus Entry and Infection
Shoemaker, Charles J.; Schornberg, Kathryn L.; Delos, Sue E.; et al.
PLOS ONE Volume: 8 Issue: 2 Article Number: e56265 Published: FEB 18 2013
78. The spatio-temporal distribution dynamics of Ebola virus proteins and RNA in infected cells
Nanbo, Asuka; Watanabe, Shinji; Halfmann, Peter; et al.
SCIENTIFIC REPORTS Volume: 3 Article Number: 1206 Published: FEB 4 2013
79. Ebola Virus Antibodies in Fruit Bats, Bangladesh
Olival, Kevin J.; Islam, Ariful; Yu, Meng; et al.
EMERGING INFECTIOUS DISEASES Volume: 19 Issue: 2 Pages: 270-273 Published: FEB 2013
80. Catheterized guinea pigs infected with Ebola Zaire virus allows safer sequential sampling to determine the pharmacokinetic profile of a phosphatidylserine-targeting monoclonal antibody
Dowall, Stuart; Taylor, Irene; Yeates, Paul; et al.
ANTIVIRAL RESEARCH Volume: 97 Issue: 2 Pages: 108-111 Published: FEB 2013
81. Inhibition of Ebola Virus Infection: Identification of Niemann-Pick C1 as the Target by Optimization of a Chemical Probe
Lee, Kyungae; Ren, Tao; Cote, Marceline; et al.
ACS MEDICINAL CHEMISTRY LETTERS Volume: 4 Issue: 2 Pages: 239-243 Published: FEB 2013
82. Inhibition of Ebola Virus Entry through Biophysical Identification of Functionally Important Residues in the GP2 Fusion Loop
Gregory, Sonia M.; White, Judith M.; Tamm, Lukas K.
Conference: 57th Annual Meeting of the Biophysical-Society Location: Philadelphia, PA Date: FEB 02-06, 2013
Sponsor(s): Biophys Soc
BIOPHYSICAL JOURNAL Volume: 104 Issue: 2 Supplement: 1 Pages: 384A-384A Published: JAN 29 2013
83. Elucidating the Mechanism of Ebola Virus Assembly and Budding
Adu-Gyamfi, Emmanuel; Soni, Smita P.; Stahelin, Robert V.
Conference: 57th Annual Meeting of the Biophysical-Society Location: Philadelphia, PA Date: FEB 02-06, 2013
Sponsor(s): Biophys Soc
BIOPHYSICAL JOURNAL Volume: 104 Issue: 2 Supplement: 1 Pages: 416A-416A Published: JAN 29 2013
84. Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates
Marzi, Andrea; Engelmann, Flora; Feldmann, Friederike; et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA Volume: 110 Issue: 5 Pages: 1893-1898 Published: JAN 29 2013
85. Compositions and methods for inhibiting expression of a gene from the ebola virus
Patent Number: US 08354390
Patent Assignee: Alnylam Pharmaceuticals Inc; The United States of America as represented by the Secretary of the Army
Inventor(s): Bavari, Sina; Warfield, Kelly Lyn; Tan, Pamela; et al.
Official Gazette of the United States Patent and Trademark Office Patents Published: JAN 15 2013
86. 4LG2: Crystal structure of Reston Ebola virus VP35 RNA binding domain bound to 12-bp dsRNA
Bale, S; Julien, J-P; Bornholdt, ZA; et al.
Worldwide Protein Data Bank
DOI: http://dx.doi.org/10.2210/pdb4lg2/pdb
Document Type: Data set
View Abstract
87. Crystal structure of Reston Ebola virus VP35 RNA binding domain bound to 12-bp dsRNA
Bale, S; Julien, J-P; Bornholdt, ZA; et al.
Nucleic Acid Database
DOI: http://dx.doi.org/10.2210/pdb4lg2/pdb
Document Type: Data set
View Abstract
88. New deuterated nitrogenated heterocyclic carboxamide useful in pharmaceutical composition as antiviral agent for e.g. influenza viruses, human respiratory syncytial virus, measles virus, mumps virus, rabies virus and Ebola virus
Patent Number: WO2013180149-A1; TW201402556-A
Patent Assignee: TOYAMA CHEM CO LTD
Inventor(s): OONISHI Y.
89. Review of Ebola Virus Infections in Domestic Animals
Weingartl, H. M.; Nfon, C.; Kobinger, G.
Edited Roth, JA; Richt, JA; Morozov, IA
Conference: Workshop on Vaccines and Diagnostics for Transboundary Animal Diseases Location: Ames, IA Date: SEP 17-19, 2012
Sponsor(s): US Dept Homeland Secur Sci & Technol Directorate; Kansas State Univ, Coll Vet Med, DHS Ctr Excellence Emerg & Zoonot Anim Dis; Iowa State Univ, Coll Vet Med, Ctr Food Secur & Publ Hlth, Inst Int Cooperat Anim Biol; Benchmark Biolabs; Boehringer Ingelheim Vetmedica Inc; Pfizer Animal Hlth; Merial Ltd; World Org Anim Hlth; Int Alliance Biol Standardizat
VACCINES AND DIAGNOSTICS FOR TRANSBOUNDARY ANIMAL DISEASES Book Series: Developments in Biologicals Volume: 135 Pages: 211-218 Published: 2013
90. [Research progress of the molecule mechanisms of Ebola virus infection of cells].
Shi, Ming; Shen, Yu-Qing
Bing du xue bao = Chinese journal of virology / [bian ji, Bing du xue bao bian ji wei yuan hui] Volume: 29 Issue: 1 Pages: 71-5 Published: 2013-Jan
91. High-throughput virtual screening and docking studies of matrix protein vp40 of ebola virus.
Tamilvanan, Thangaraju; Hopper, Waheeta
Bioinformation Volume: 9 Issue: 6 Pages: 286-92 Published: 2013 (Epub 2013 Mar 19)
92. Expression of concern: Serological evidence of Ebola virus infection in Indonesian orangutans.
Corporate Author(s): PLOS ONE Editors
PloS one Volume: 8 Issue: 3 Pages: e60289 Published: 2013 (Epub 2013 Mar 20)
93. An Upstream Open Reading Frame Modulates Ebola Virus Polymerase Translation and Virus Replication
Shabman, Reed S.; Hoenen, Thomas; Groseth, Allison; et al.
PLOS PATHOGENS Volume: 9 Issue: 1 Article Number: e1003147 Published: JAN 2013
94. Set of oligonucleotide primers and fluorescent-labeled probes for species-specific express-identification of virus ebola-sudan by method of polymerase chain reaction
Patent Number: RU2487167-C1
Patent Assignee: LEGAL PROTECTION INTELLECTUAL ACTIVITY; VORON REGION PENAL COLONY NO 1
Inventor(s): AGAFONOV A P; SEMENTSOVA A O; SERGEEV A N; et al.
95. Set of oligonucleotide primers and fluorescent-marked probes for type-specific express identification of ebola-zaire virus by method of polymerase chain reaction
Patent Number: RU2487942-C1
Patent Assignee: VECTOR VIROLOGY & BIOTECHN RES CENT
Inventor(s): AGAFONOV A P; SEMENTSOVA A O; SERGEEV A N; et al.
96. New chimeric antigen receptor used in tumor therapy comprises human anti-Ebola virus latent membrane protein 1 single chain antibody, specific fragments of human immunoglobulin G antibody and immune co-stimulating signal molecules
Patent Number: CN103145849-A
Patent Assignee: FENG Z
Inventor(s): CHEN R; FENG Z; SONG X; et al.
97. New heterocyclic compounds used for treating e.g. lung carcinoma, pancreatic carcinoma, bladder carcinoma, colon carcinoma, Ebola virus disease, Alzheimer's, Parkinson's disease and amyotrophic lateral sclerosis
Patent Number: WO2013171641-A1
Patent Assignee: NOVARTIS AG
Inventor(s): FURET P; GROTZFELD R M; JONES D B; et al.
98. New antibody or its antigen binding fragment useful in pharmaceutical composition for treating viral infections including Rous sarcoma virus, Ebola virus, HIV and influenza virus, cancer and inflammatory disease
Patent Number: US2013149300-A1; WO2013095738-A2; WO2013095738-A3
Patent Assignee: ICON GENETICS GMBH; MAPP BIOPHARMACEUTICAL INC; HIATT A; ZEITLIN L
Inventor(s): HIATT A; ZEITLIN L.
99. New substituted N-(2-((2-amino-2-oxo-ethyl)amino)-2-oxo-ethyl)-2-methylamino-acetamide compounds are furin proprotein convertase inhibitors, useful for treating e.g. infectious disease e.g. ebola virus, cancer, and autoimmune disorder
Patent Number: WO2013138666-A1
Patent Assignee: SANFORD BURNHAM MEDICAL RES INST
Inventor(s): PELLECCHIA M; BARILE E; STRONGIN A.
100. Use of compound selected from substituted triazine compound, substituted 1,3-diphenyl-urea compound or substituted heterocyclic compound for inhibiting viral infection e.g. Ebola virus infection in a mammal
Patent Number: WO2013152223-A2
Patent Assignee: UNIV ILLINOIS FOUND
Inventor(s): PRABHAKAR B S; ELSHABRAWY H A
101. New genetic marker molecule comprises nucleotides of Ebola virus (EBOV) nucleoprotein (NP) gene, useful for detecting EBOV
Patent Number: CN103045755-A
Patent Assignee: SHANGHAI VETERINARY INST CHINESE ACAD AG
Inventor(s): LI B; SHI Z; MA Z; et al.
102. Expression of the VP40 gene of Ebola virus and development of recombinant protein-based indirect ELISA for antibody detection.
Gai WeiWei; Zheng XueXing; Xue XiangHong; et al.
Zhongguo Bingyuan Shengwuxue Zazhi / Journal of Pathogen Biology Volume: 8 Issue: 9 Pages: 782-786 Published: 2013
103. 埃博拉病毒VP40蛋白的原核表达及其抗体间接ELISA检测方法的建立
Expression of the VP40 gene of Ebola virus and development of recombinant protein-based indirect ELISA for antibody detection
盖微微; 郑学星; 薛向红; et al.
Gai Weiwei; Zheng Xuexing; Xue Xianghong; et al.
中国病原生物学杂志 Volume: 8 Issue: 9 Pages: 782-786 Article Number: 1673-5234(2013)8:9<782:ablbdv>2.0.TX;2-H Published: 2013
Journal of Pathogen Biology Volume: 8 Issue: 9 Pages: 782-786 Article Number: 1673-5234(2013)8:9<782:ablbdv>2.0.TX;2-H Published: 2013
104. Recombinant lentogenic Newcastle disease virus expressing Ebola virus GP infects cells independently of exogenous trypsin and uses macropinocytosis as the major pathway for cell entry.
Wen ZhiYuan; Zhao BoLin; Song Kun; et al.
Virology Journal Volume: 10 Issue: 331 Pages: (9 November 2013) Published: 2013
105. 埃博拉疫苗研究新进展
Recent advances in Ebola virus vaccine development
郑学星; 杨松涛; 王化磊; et al.
Zheng Xuexing; Yang Songtao; Wang Hualei; et al.
中国病原生物学杂志 Volume: 8 Issue: 7 Pages: 652-655 Article Number: 1673-5234(2013)8:7<652:ablymy>2.0.TX;2-G Published: 2013
Journal of Pathogen Biology Volume: 8 Issue: 7 Pages: 652-655 Article Number: 1673-5234(2013)8:7<652:ablymy>2.0.TX;2-G Published: 2013
106. New cell comprising disruption of genes, where the disruption results in decreased expression/activity of the genes in the cell, useful for replicating virus such as influenza/Ebola/Marburg, and for treating viral infection e.g. hepatitis B
Patent Number: WO2013106548-A1
Patent Assignee: BROAD INST INC; MASSACHUSETTS GEN HOSPITAL
Inventor(s): DEGRACE M; HACOHEN N; SHAPIRA S; et al.
107. 表达扎伊尔型埃博拉病毒囊膜糖蛋白重组水泡性口炎病毒的构建
Construction of a recombinant vesicular stomatitis virus expressing Zaire Ebola virus glycoprotein
宋坤; 王喜军; 温志远; et al.
Song Kun; Wang Xijun; Wen Zhiyuan; et al.
中国预防兽医学报 Volume: 35 Issue: 6 Pages: 431-435 Article Number: 1008-0589(2013)35:6<431:bdzyex>2.0.TX;2-4 Published: 2013
Chinase Journal of Preventive Veterinary Medicine Volume: 35 Issue: 6 Pages: 431-435 Article Number: 1008-0589(2013)35:6<431:bdzyex>2.0.TX;2-4 Published: 2013
108. 埃博拉病毒检测与分型Real-time PCR方法的建立
Development of a real-time PCR method to detect and type Ebola virus
盖微微; 郑学星; 薛向红; et al.
Gai Weiwei; Zheng Xuexing; Xue Xianghong; et al.
中国病原生物学杂志 Volume: 8 Issue: 3 Pages: 208-211,216 Article Number: 1673-5234(2013)8:3<208:ablbdj>2.0.TX;2-8 Published: 2013
Journal of Pathogen Biology Volume: 8 Issue: 3 Pages: 208-211,216 Article Number: 1673-5234(2013)8:3<208:ablbdj>2.0.TX;2-8 Published: 2013
109. An Upstream Open Reading Frame Modulates Ebola Virus Polymerase Translation and Virus Replication.
Shabman, Reed S; Binning, Jennifer M; Amarasinghe, Gaya K; et al.
Figshare
Source URL: http://figshare.com/articles/An_Upstream_Open_Reading_Frame_Modulates_Ebola_Virus_Polymerase_Translation_and_Virus_Replication__/155277 Version: 1
Document Type: Data study
View Abstract
110. Multiple Cationic Amphiphiles Induce a Niemann-Pick C Phenotype and Inhibit Ebola Virus Entry and Infection.
Shoemaker, Charles J; Schornberg, Kathryn L; Delos, Sue E; et al.
Figshare
Source URL: http://figshare.com/articles/Multiple_Cationic_Amphiphiles_Induce_a_Niemann_Pick_C_Phenotype_and_Inhibit_Ebola_Virus_Entry_and_Infection__/157285 Version: 1
Document Type: Data study
View Abstract
111. Lectin-Dependent Enhancement of Ebola Virus Infection via Soluble and Transmembrane C-type Lectin Receptors.
Stahl, Gregory L; Kotton, Darrell N; Takahashi, Kazue; et al.
Figshare
Source URL: http://figshare.com/articles/_Lectin_Dependent_Enhancement_of_Ebola_Virus_Infection_via_Soluble_and_Transmembrane_C_type_Lectin_Receptors_/664832 Version: 1
Document Type: Data study
View Abstract
112. New peptide having specific amino acid sequence used for the treatment of a pathogen infection such as Pseudomonas, Aeromonas, Shigella, Influenza virus A, parainfluenza, Newcastle disease virus and Ebola virus infection in a subject
Patent Number: WO2013029182-A1
Patent Assignee: SOCPRA SCI SANTE&HUMAINES
Inventor(s): DAY R; NEUGEBAUER W A; DORY Y.
113. Blood Hematology Results for Cynomolgus Monkeys after vaccination and challenge with Ebola Virus..
Feldmann, Friedericke; Alimonti, Judie B; Jones, Steven M; et al.
Figshare
DOI: http://dx.doi.org/10.1371/journal.pone.0005547.t001
Document Type: Data set
View Abstract
114. Research progress on ebola virus glycoprotein.
Ding GuoYong; Wang ZhiYu; Gao Lu; et al.
Chinese Journal of Virology Volume: 29 Issue: 2 Pages: 233-237 Published: 2013
115. Research progress of the molecule mechanisms of Ebola virus infection of cells.
Shi Ming; Shen YuQing
Chinese Journal of Virology Volume: 29 Issue: 1 Pages: 71-75 Published: 2013
116. The spatio-temporal distribution dynamics of Ebola virus proteins and RNA in infected cells.
Nanbo, A.; Watanabe, S.; Halfmann, P.; et al.
Scientific Reports Volume: 3 Issue: 1206 Pages: srep01206 Published: 2013
117. Clinical Manifestations and Case Management of Ebola Haemorrhagic Fever Caused by a Newly Identified Virus Strain, Bundibugyo, Uganda, 2007-2008
Roddy, Paul; Howard, Natasha; Van Kerkhove, Maria D.; et al.
PLOS ONE Volume: 7 Issue: 12 Article Number: e52986 Published: DEC 28 2012
118. A replication-deficient rabies virus vaccine expressing Ebola virus glycoprotein is highly attenuated for neurovirulence
Papaneri, Amy B.; Wirblich, Christoph; Cann, Jennifer A.; et al.
VIROLOGY Volume: 434 Issue: 1 Pages: 18-26 Published: DEC 5 2012
119. Use of the Syrian Hamster as a New Model of Ebola Virus Disease and Other Viral Hemorrhagic Fevers
Wahl-Jensen, Victoria; Bollinger, Laura; Safronetz, David; et al.
VIRUSES-BASEL Volume: 4 Issue: 12 Pages: 3754-3784 Published: DEC 2012
120. Cathepsin B & L Are Not Required for Ebola Virus Replication
Marzi, Andrea; Reinheckel, Thomas; Feldmann, Heinz
PLOS NEGLECTED TROPICAL DISEASES Volume: 6 Issue: 12 Article Number: e1923 Published: DEC 2012
121. Antigenic Subversion: A Novel Mechanism of Host Immune Evasion by Ebola Virus
Mohan, Gopi S.; Li, Wenfang; Ye, Ling; et al.
PLOS PATHOGENS Volume: 8 Issue: 12 Article Number: e1003065 Published: DEC 2012
122. Ebola Virus Genome Plasticity as a Marker of Its Passaging History: A Comparison of In Vitro Passaging to Non-Human Primate Infection
Kugelman, Jeffrey R.; Lee, Michael S.; Rossi, Cynthia A.; et al.
PLOS ONE Volume: 7 Issue: 11 Article Number: e50316 Published: NOV 28 2012
123. Two Synthetic Antibodies that Recognize and Neutralize Distinct Proteolytic Forms of the Ebola Virus Envelope Glycoprotein
Koellhoffer, Jayne F.; Chen, Gang; Sandesara, Rohini G.; et al.
CHEMBIOCHEM Volume: 13 Issue: 17 Pages: 2549-2557 Published: NOV 26 2012
124. Transmission of Ebola virus from pigs to non-human primates
Weingartl, Hana M.; Embury-Hyatt, Carissa; Nfon, Charles; et al.
SCIENTIFIC REPORTS Volume: 2 Article Number: 811 Published: NOV 15 2012
125. Single-Particle Tracking Demonstrates that Actin Coordinates the Movement of the Ebola Virus Matrix Protein
Adu-Gyamfi, Emmanuel; Digman, Michelle A.; Gratton, Enrico; et al.
BIOPHYSICAL JOURNAL Volume: 103 Issue: 9 Pages: L41-L43 Published: NOV 7 2012
126. A multiagent filovirus DNA vaccine delivered by intramuscular electroporation completely protects mice from ebola and Marburg virus challenge
Grant-Klein, Rebecca J.; Van Deusen, Nicole M.; Badger, Catherine V.; et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS Volume: 8 Issue: 11 Special Issue: SI Pages: 1703-1706 Published: NOV 2012
127. Discovery and Early Development of AVI-7537 and AVI-7288 for the Treatment of Ebola Virus and Marburg Virus Infections
Iversen, Patrick L.; Warren, Travis K.; Wells, Jay B.; et al.
VIRUSES-BASEL Volume: 4 Issue: 11 Pages: 2806-2830 Published: NOV 2012
128. Profiling the Native Specific Human Humoral Immune Response to Sudan Ebola Virus Strain Gulu by Chemiluminescence Enzyme-Linked Immunosorbent Assay
Sobarzo, Ariel; Perelman, Eddie; Groseth, Allison; et al.
CLINICAL AND VACCINE IMMUNOLOGY Volume: 19 Issue: 11 Pages: 1844-1852 Published: NOV 2012
129. Generation and epitope mapping of a monoclonal antibody against nucleoprotein of Ebola virus.
Wang, Xiaodu; Liu, Yang; Wang, Haoting; et al.
Sheng wu gong cheng xue bao = Chinese journal of biotechnology Volume: 28 Issue: 11 Pages: 1317-27 Published: 2012-Nov
130. Immune Parameters Correlate with Protection Against Ebola Virus Infection in Rodents and Nonhuman Primates
Wong, Gary; Richardson, Jason S.; Pillet, Stephane; et al.
SCIENCE TRANSLATIONAL MEDICINE Volume: 4 Issue: 158 Article Number: 158ra146 Published: OCT 31 2012
131. Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques
Olinger, Gene Garrard, Jr.; Pettitt, James; Kim, Do; et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA Volume: 109 Issue: 44 Pages: 18030-18035 Published: OCT 30 2012
132. Democratic Republic of the Congo 3 Ebola-Like Virus Found
[Anonymous]
SCIENCE Volume: 338 Issue: 6103 Pages: 22-22 Published: OCT 5 2012
133. High Content Image Based Analysis Identifies Cell Cycle Inhibitors as Regulators of Ebola Virus Infection
Kota, Krishna P.; Benko, Jacqueline G.; Mudhasani, Rajini; et al.
VIRUSES-BASEL Volume: 4 Issue: 10 Pages: 1865-1877 Published: OCT 2012
134. The Baboon (Papio spp.) as a Model of Human Ebola Virus Infection
Perry, Donna L.; Bollinger, Laura; White, Gary L.
VIRUSES-BASEL Volume: 4 Issue: 10 Pages: 2400-2416 Published: OCT 2012
135. Further characterization of the immune response in mice to inactivated and live rabies vaccines expressing Ebola virus glycoprotein
Papaneri, Amy B.; Wirblich, Christoph; Cooper, Kurt; et al.
VACCINE Volume: 30 Issue: 43 Pages: 6136-6141 Published: SEP 21 2012
136. Development of SYBR Green I real-time RT-PCR for the Detection of Ebola Virus
Liu Yang; Shi Zi-xue; Ma Yu-kun; et al.
Chinese Journal of Virology Volume: 28 Issue: 5 Pages: 567-571 Published: SEP 2012
137. Ebola virus induces a differential cytokine response and NFKB activation in infected cells
Olejnik, J.; Marzi, A.; Feldmann, H.; et al.
Conference: 10th Joint Meeting of the International-Cytokine-Society (ICS) / Meeting of the International-Society-for-Interferon-and-Cytokine-Research (ISICR) Location: Geneva, SWITZERLAND Date: SEP 11-14, 2012
Sponsor(s): Int Cytokine Soc (ICS); Int Soc Interferon & Cytokine Res (ISICR)
CYTOKINE Volume: 59 Issue: 3 Special Issue: SI Pages: 523-523 Published: SEP 2012
138. How Ebola Virus Counters the Interferon System
Kuehl, A.; Poehlmann, S.
ZOONOSES AND PUBLIC HEALTH Volume: 59 Special Issue: SI Supplement: 2 Pages: 116-131 Published: SEP 2012
139. Reemerging Sudan Ebola Virus Disease in Uganda, 2011
Shoemaker, Trevor; MacNeil, Adam; Balinandi, Stephen; et al.
EMERGING INFECTIOUS DISEASES Volume: 18 Issue: 9 Pages: 1480-1483 Published: SEP 2012
140. [Development of SYBR Green I real-time RT-PCR for the detection of Ebola virus].
Liu, Yang; Shi, Zi-Xue; Ma, Yu-Kun; et al.
Bing du xue bao = Chinese journal of virology / [bian ji, Bing du xue bao bian ji wei yuan hui] Volume: 28 Issue: 5 Pages: 567-71 Published: 2012-Sep
141. The Ebola Virus Glycoprotein Contributes to but Is Not Sufficient for Virulence In Vivo
Groseth, Allison; Marzi, Andrea; Hoenen, Thomas; et al.
PLOS PATHOGENS Volume: 8 Issue: 8 Article Number: e1002847 Published: AUG 2012
142. Monoclonal Antibody 3D12 Anti-Ebola Virus NP
Wang, Xiaodu
HYBRIDOMA Volume: 31 Issue: 4 Pages: 296-296 Published: AUG 2012
143. [Multiplex real-time PCR method for rapid detection of Marburg virus and Ebola virus].
Yang, Yu; Bai, Lin; Hu, Kong-Xin; et al.
Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology Volume: 26 Issue: 4 Pages: 313-5 Published: 2012-Aug
144. Serological Evidence of Ebola Virus Infection in Indonesian Orangutans
Nidom, Chairul A.; Nakayama, Eri; Nidom, Reviany V.; et al.
PLOS ONE Volume: 7 Issue: 7 Article Number: e40740 Published: JUL 18 2012
145. Assembly of Ebola Virus Matrix Protein VP40 Is Regulated by Latch-Like Properties of N and C Terminal Tails
Silva, Leslie P.; Vanzile, Michael; Bavari, Sina; et al.
PLOS ONE Volume: 7 Issue: 7 Article Number: e39978 Published: JUL 5 2012
146. Ebola Virus Antibodies in Fruit Bats, Ghana, West Africa
Hayman, David T. S.; Yu, Meng; Crameri, Gary; et al.
EMERGING INFECTIOUS DISEASES Volume: 18 Issue: 7 Pages: 1207-1209 Published: JUL 2012
147. Prediction and identification of mouse cytotoxic T lymphocyte epitopes in Ebola virus glycoproteins
Wu, Shipo; Yu, Ting; Song, Xiaohong; et al.
VIROLOGY JOURNAL Volume: 9 Article Number: 111 Published: JUN 13 2012
148. Successful Treatment of Ebola Virus-Infected Cynomolgus Macaques with Monoclonal Antibodies
Qiu, Xiangguo; Audet, Jonathan; Wong, Gary; et al.
SCIENCE TRANSLATIONAL MEDICINE Volume: 4 Issue: 138 Article Number: 138ra81 Published: JUN 13 2012
149. The entry of Ebola and Marburg viruses: interaction between the viral glycoprotein and cellular factors
Cote, Marceline; Cunningham, James M.
VIROLOGIE Volume: 16 Issue: 3 Pages: 168-177 Published: MAY-JUN 2012
150. Anti-Tetherin Activities of HIV-1 Vpu and Ebola Virus Glycoprotein Do Not Involve Removal of Tetherin from Lipid Rafts
Lopez, Lisa A.; Yang, Su Jung; Exline, Colin M.; et al.
JOURNAL OF VIROLOGY Volume: 86 Issue: 10 Pages: 5467-5480 Published: MAY 2012
151. Ebola virus entry requires the host-programmed recognition of an intracellular receptor
Miller, Emily Happy; Obernosterer, Gregor; Raaben, Matthijs; et al.
EMBO JOURNAL Volume: 31 Issue: 8 Pages: 1947-1960 Published: APR 18 2012
152. Structural dissection of Ebola virus and its assembly determinants using cryo-electron tomography
Bharat, Tanmay A. M.; Noda, Takeshi; Riches, James D.; et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA Volume: 109 Issue: 11 Pages: 4275-4280 Published: MAR 13 2012
153. Ebola GP-Specific Monoclonal Antibodies Protect Mice and Guinea Pigs from Lethal Ebola Virus Infection
Qiu, Xiangguo; Fernando, Lisa; Melito, P. Leno; et al.
PLOS NEGLECTED TROPICAL DISEASES Volume: 6 Issue: 3 Article Number: e1575 Published: MAR 2012
154. Characterization of the RNA Silencing Suppression Activity of the Ebola Virus VP35 Protein in Plants and Mammalian Cells
Zhu, Yali; Cherukuri, Nil Celebi; Jackel, Jamie N.; et al.
JOURNAL OF VIROLOGY Volume: 86 Issue: 6 Pages: 3038-3049 Published: MAR 2012
155. Structure of an Antibody in Complex with Its Mucin Domain Linear Epitope That Is Protective against Ebola Virus
Olal, Daniel; Kuehne, Ana I.; Bale, Shridhar; et al.
JOURNAL OF VIROLOGY Volume: 86 Issue: 5 Pages: 2809-2816 Published: MAR 2012
156. Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression
Gnirss, Kerstin; Kuehl, Annika; Karsten, Christina; et al.
VIROLOGY Volume: 424 Issue: 1 Pages: 3-10 Published: MAR 1 2012
157. Brote de Fiebre Hemorrágica por el virus del Ébola en Uganda
Hemorrhagic Fever outbreak due to Ebola virus in Uganda
Aríñez Fernández, MªC.
Sanidad Militar Volume: 68 Issue: 1 Pages: 33-35 Published: 2012-03
158. Productive Replication of Ebola Virus Is Regulated by the c-Abl1 Tyrosine Kinase
Garcia, Mayra; Cooper, Arik; Shi, Wei; et al.
SCIENCE TRANSLATIONAL MEDICINE Volume: 4 Issue: 123 Article Number: 123ra24 Published: FEB 29 2012
159. The Ebola Virus Interferon Antagonist VP24 Directly Binds STAT1 and Has a Novel, Pyramidal Fold
Zhang, Adrianna P. P.; Bornholdt, Zachary A.; Liu, Tong; et al.
PLOS PATHOGENS Volume: 8 Issue: 2 Article Number: e1002550 Published: FEB 2012
160. A strategy to simultaneously eradicate the natural reservoirs of rabies and Ebola virus
Wong, Gary; Kobinger, Gary
EXPERT REVIEW OF VACCINES Volume: 11 Issue: 2 Pages: 163-166 Published: FEB 2012
161. Induction of ebolavirus cross-species immunity using retrovirus-like particles bearing the Ebola virus glycoprotein lacking the mucin-like domain
Ou, Wu; Delisle, Josie; Jacques, Jerome; et al.
VIROLOGY JOURNAL Volume: 9 Article Number: 32 Published: JAN 25 2012
162. The Organisation of Ebola Virus Reveals a Capacity for Extensive, Modular Polyploidy
Beniac, Daniel R.; Melito, Pasquale L.; Devarennes, Shauna L.; et al.
PLOS ONE Volume: 7 Issue: 1 Article Number: e29608 Published: JAN 11 2012
163. Composition, useful to treat viral infections and promote virolysis of a virus (HIV-1, influenza, Ebola or dengue) in a mammal (human), comprises a peptide having a specified amino acid sequence
Patent Number: WO2012048033-A2; WO2012048033-A3; US2014050793-A1
Patent Assignee: UNIV DREXEL; PHILADELPHIA HEALTH&EDUCATION CORP
Inventor(s): CHAIKEN I; PAPAZOGLOU E; BASTIAN A R; et al.
UC-eLinks
164. New dodecahydro-phenothiazine compounds prepared by reacting 3-pyrrolidin-1-yl-dodecahydro-phenothiazine compound with potassium hydroxide in dioxane at room temperature, useful for treating viral disease e.g. Ebola virus in mammal
Patent Number: US2012270854-A1; WO2012145567-A1; EP2699241-A1
Patent Assignee: PROSETTA ANTIVIRAL INC
Inventor(s): HURT C; LINGAPPA V; FREEMAN B; et al.
UC-eLinks
165. Peptide-bonded liposome useful for treating hemorrhagic fever caused by Ebola virus, comprises 9-mer continuous partial sequence included in amino acid sequence of Ebola-virus antigenic protein, or specific amino acid sequence
Patent Number: WO2012050193-A1; JP2014005205-A
Patent Assignee: UNIV SAITAMA MEDICAL; JAPAN NAT INST INFECTIOUS DISEASES; NOF CORP; KOKURITSU YOBO EISEI KENKYUSHO; NIPPON OILS & FATS CO LTD
Inventor(s): MATSUI M; UCHIDA T; TANEICHI M; et al.
UC-eLinks
166. The Organisation of Ebola Virus Reveals a Capacity for Extensive, Modular Polyploidy.
DeVarennes, Shauna L; Hiebert, Shannon L; Rabb, Melissa J; et al.
Figshare
Source URL: http://figshare.com/articles/The_Organisation_of_Ebola_Virus_Reveals_a_Capacity_for_Extensive_Modular_Polyploidy/129873 Version: 1
Document Type: Data study
167. The Ebola Virus Interferon Antagonist VP24 Directly Binds STAT1 and Has a Novel, Pyramidal Fold.
Woods, Virgil L, Jr; Zhang, Adrianna PP; Liu, Tong; et al.
Figshare
Source URL: http://figshare.com/articles/The_Ebola_Virus_Interferon_Antagonist_VP24_Directly_Binds_STAT1_and_Has_a_Novel_Pyramidal_Fold/128379 Version: 1
Document Type: Data study
168. Ebola virus outbreaks in Africa: Past and present
Muyembe-Tamfum, J. J.; Mulangu, S.; Masumu, Justin; et al.
Conference: Conference of the Southern-African-Centre-for-Infectious-Disease-Surveillance One Health Location: Natl Inst Communicable Dis, Johannesburg, SOUTH AFRICA Date: JUL, 2011
Sponsor(s): So African Ctr Infect Dis Surveillance
ONDERSTEPOORT JOURNAL OF VETERINARY RESEARCH Volume: 79 Issue: 2 Supplement: 3 Article Number: 451 Published: 2012
169. Serological Evidence of Ebola Virus Infection in Indonesian Orangutans.
Alamudi, Mohamad Y; Daulay, Syafril; Dharmayanti, Indi NLP; et al.
Figshare
Source URL: http://figshare.com/articles/Serological_Evidence_of_Ebola_Virus_Infection_in_Indonesian_Orangutans/122605 Version: 1
Document Type: Data study
170. The Ebola Virus Glycoprotein Contributes to but Is Not Sufficient for Virulence In Vivo.
Groseth, Allison; Herwig, Astrid; Gardner, Don; et al.
Figshare
Source URL: http://figshare.com/articles/The_Ebola_Virus_Glycoprotein_Contributes_to_but_Is_Not_Sufficient_for_Virulence_In_Vivo_/121882 Version: 1
Document Type: Data study
171. Antigenic Subversion: A Novel Mechanism of Host Immune Evasion by Ebola Virus.
Mohan, Gopi S; Yang, Chinglai; Li, Wenfang; et al.
Figshare
Source URL: http://figshare.com/articles/Antigenic_Subversion_A_Novel_Mechanism_of_Host_Immune_Evasion_by_Ebola_Virus__/116350 Version: 1
Document Type: Data study
172. Assembly of Ebola Virus Matrix Protein VP40 Is Regulated by Latch-Like Properties of N and C Terminal Tails.
Vanzile, Michael; Bavari, Sina; Aman, JM Javad; et al.
Figshare
Source URL: http://figshare.com/articles/Assembly_of_Ebola_Virus_Matrix_Protein_VP40_Is_Regulated_by_Latch_Like_Properties_of_N_and_C_Terminal_Tails/123307 Version: 1
Document Type: Data study
173. Ebola virus outbreaks in Africa: Past and present
Muyembe-Tamfum, J.J.; Mulangu, S.; Masumu, Justin; et al.
Onderstepoort Journal of Veterinary Research Volume: 79 Issue: 2 Pages: 06-13 Published: 2012
174. In vivo replication and pathogenesis of vesicular stomatitis virus recombinant M40 containing Ebola virus L-domain sequences.
Irie, T.; Carnero, E.; Garcia-Sastre, A.; et al.
Infectious Diseases: Research and Treatment Volume: 5 Pages: 59-64 Published: 2012
175. Use of specific tyrosine kinase inhibitor for treating or prophylactically treating filovirus infection e.g. Ebola or Marburg virus in patient
Patent Number: WO2012118599-A1
Patent Assignee: UNIV EMORY; US DEPT HEALTH&HUMAN SERVICES
Inventor(s): KALMAN D; NABEL G J; GARCIA M; et al.
UC-eLinks
176. Multiplex real-time PCR method for rapid detection of Marburg virus and Ebola virus.
Yang Yu; Bai Lin; Hu KongXin; et al.
Chinese Journal of Experimental and Clinical Virology Volume: 26 Issue: 4 Pages: 313-315 Published: 2012
177. Transmission of Ebola virus from pigs to non-human primates.
Weingartl, H. M.; Embury-Hyatt, C.; Nfon, C.; et al.
Scientific Reports Volume: 2 Issue: 811 Pages: srep00811 Published: 2012
178. 埃博拉病毒NP蛋白的单克隆抗体制备及抗原肽的定位
Generation and epitope mapping of a monoclonal antibody against nucleoprotein of Ebola virus
王晓杜; 刘阳; 王皓婷; et al.
Wang Xiaodu; Liu Yang; Wang Haoting; et al.
生物工程学报 Volume: 28 Issue: 11 Pages: 1317-1327 Article Number: 1000-3061(2012)28:11<1317:gaemoa>2.0.TX;2-B Published: 2012
Chinese Journal of Biotechnology Volume: 28 Issue: 11 Pages: 1317-1327 Article Number: 1000-3061(2012)28:11<1317:gaemoa>2.0.TX;2-B Published: 2012
179. EBOV-Z和MARV的NP基因在杆状病毒表达系统的表达及反应原性鉴定
Expression and Characterization of Nucleocapsid Protein of Ebola-Zaire and Marburg Viruses in Baculovirus
王宗尧; 史子学; 刘阳; et al.
Wang Zongyao; Shi Zixue; Liu Yang; et al.
生物技术通报 Issue: 9 Pages: 104-108 Article Number: 1002-5464(2012)9<104:ezhmdn>2.0.TX;2-Q Published: 2012
Biotechnology Bulletin Issue: 9 Pages: 104-108 Article Number: 1002-5464(2012)9<104:ezhmdn>2.0.TX;2-Q Published: 2012
180. Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques.
Olinger, G. G., Jr.; Pettitt, J.; Kim, D.; et al.
Proceedings of the National Academy of Sciences of the United States of America Volume: 109 Issue: 44 Pages: 18030-18035 Published: 2012
181. Ebola virus outbreaks in Africa: past and present.
Muyembe-Tamfum, J. J.; Mulangu, S.; Masumu, J.; et al.
Conference: Proceedings of the Conference of the Southern African Centre for Infectious Disease Surveillance, National Institute for Communicable Diseases, Johannesburg, South Africa, July 2011.
Onderstepoort Journal of Veterinary Research Volume: 79 Issue: 2 Pages: Art 451 Published: 2012
182. EMD-2043: Structural dissection of Ebola virus and its assembly determinants using cryo-electron tomography.
Bharat, TAM; Noda, T; Riches, JD; et al.
Electron Microscopy Data Bank
Source URL: http://www.ebi.ac.uk/pdbe-srv/emsearch/atlas/2043_summary.html
Document Type: Data study
183. Early diagnostic technique for ebola hemorrhagic fever in individuals presumably infected with such virus
Patent Number: RU2450274-C1
Patent Assignee: NIZHEGOROD EPIDEMICS MICROBIOLOG INST
Inventor(s): ZUBAVICHENE N M; STAVSKII E A.
UC-eLinks
184. Transcription profiling of cynomolgus macaques sequential blood samples infected with Ebola virus.
Rubins, KH; Hensley, LE; Wahl-Jensen, V; et al.
ArrayExpress Archive
Source URL: http://www.ebi.ac.uk/arrayexpress/experiments/E-SMDB-4098
Document Type: Data study
185. 3V7O: Crystal structure of the C-terminal domain of Ebola virus VP30 (strain Reston-89).
Anonymous
Protein Data Bank
Source URL: http://www.rcsb.org/pdb/explore/explore.do?structureId=3V7O
Document Type: Data set
186. Establishment of one step MGB real-time RT-PCR for detection of Ebola virus Zaire and Sudan subtypes.
Liu Yang; Shi ZiXue; Wang ShuiMing; et al.
Chinese Journal of Zoonoses Volume: 28 Issue: 4 Pages: 343-346, 350 Published: 2012
187. Inhibition of Lassa virus and Ebola virus infection in host cells treated with the kinase inhibitors genistein and tyrphostin
Kolokoltsov, Andrey A.; Adhikary, Shramika; Garver, Jennifer; et al.
ARCHIVES OF VIROLOGY Volume: 157 Issue: 1 Pages: 121-127 Published: JAN 2012
188. Induction of ebolavirus cross-species immunity using retrovirus-like particles bearing the Ebola virus glycoprotein lacking the mucin-like domain.
Ou, W.; Delisle, J.; Jacques, J.; et al.
Virology Journal Volume: 9 Issue: 32 Pages: (25 January 2012) Published: 2012
189. Cathepsin Cleavage Potentiates the Ebola Virus Glycoprotein To Undergo a Subsequent Fusion-Relevant Conformational Change
Brecher, Matthew; Schornberg, Kathryn L.; Delos, Sue E.; et al.
JOURNAL OF VIROLOGY Volume: 86 Issue: 1 Pages: 364-372 Published: JAN 2012
190. Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant
Zeitlin, Larry; Pettitt, James; Scully, Corinne; et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA Volume: 108 Issue: 51 Pages: 20690-20694 Published: DEC 20 2011
191. A nonreplicating subunit vaccine protects mice against lethal Ebola virus challenge
Phoolcharoen, Waranyoo; Dye, John M.; Kilbourne, Jacquelyn; et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA Volume: 108 Issue: 51 Pages: 20695-20700 Published: DEC 20 2011
192. Biophysical Characterization and Conformational Stability of Ebola and Marburg Virus-Like Particles
Hu, Lei; Trefethen, Jared M.; Zeng, Yuhong; et al.
JOURNAL OF PHARMACEUTICAL SCIENCES Volume: 100 Issue: 12 Pages: 5156-5173 Published: DEC 2011
193. Ebola Virus Glycoprotein Needs an Additional Trigger, beyond Proteolytic Priming for Membrane Fusion
Bale, Shridhar; Liu, Tong; Li, Sheng; et al.
PLOS NEGLECTED TROPICAL DISEASES Volume: 5 Issue: 11 Article Number: e1395 Published: NOV 2011
194. Ebola Virus Enters Host Cells by Macropinocytosis and Clathrin-Mediated Endocytosis
Aleksandrowicz, Paulina; Marzi, Andrea; Biedenkopf, Nadine; et al.
JOURNAL OF INFECTIOUS DISEASES Volume: 204 Supplement: 3 Pages: S957-S967 Published: NOV 1 2011
195. Recombinant Vesicular Stomatitis Virus-Based Vaccines Against Ebola and Marburg Virus Infections
Geisbert, Thomas W.; Feldmann, Heinz
JOURNAL OF INFECTIOUS DISEASES Volume: 204 Supplement: 3 Pages: S1075-S1081 Published: NOV 1 2011
196. Emergence of Divergent Zaire Ebola Virus Strains in Democratic Republic of the Congo in 2007 and 2008
Grard, Gilda; Biek, Roman; Tamfum, Jean-Jacques Muyembe; et al.
JOURNAL OF INFECTIOUS DISEASES Volume: 204 Supplement: 3 Pages: S776-S784 Published: NOV 1 2011
197. Management of Accidental Exposure to Ebola Virus in the Biosafety Level 4 Laboratory, Hamburg, Germany
Guenther, Stephan; Feldmann, Heinz; Geisbert, Thomas W.; et al.
JOURNAL OF INFECTIOUS DISEASES Volume: 204 Supplement: 3 Pages: S785-S790 Published: NOV 1 2011
198. sGP Serves as a Structural Protein in Ebola Virus Infection
Iwasa, Ayaka; Shimojima, Masayuki; Kawaoka, Yoshihiro
JOURNAL OF INFECTIOUS DISEASES Volume: 204 Supplement: 3 Pages: S897-S903 Published: NOV 1 2011
199. Contribution of Sec61 alpha to the Life Cycle of Ebola Virus
Iwasa, Ayaka; Halfmann, Peter; Noda, Takeshi; et al.
JOURNAL OF INFECTIOUS DISEASES Volume: 204 Supplement: 3 Pages: S919-S926 Published: NOV 1 2011
200. Comparative Analysis of Ebola Virus Glycoprotein Interactions With Human and Bat Cells
Kuehl, Annika; Hoffmann, Markus; Mueller, Marcel A.; et al.
JOURNAL OF INFECTIOUS DISEASES Volume: 204 Supplement: 3 Pages: S840-S849 Published: NOV 1 2011
No comments:
Post a Comment
Your comment will appear after it is approved